Boehringer Ingelheim

Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.


Vision & Values

For over 130 years, since our foundation by Albert Boehringer, our focus is on long-term performance rather than being limited by short-term profits.

Day by day, the 50,000 employees of Boehringer Ingelheim create value through innovation with a clear goal: to provide more health and improve the lives of both humans and animals.


Diversity & Inclusion

We at Boehringer Ingelheim value and respect the differences of our people and nurture a diverse, collaborative and open company culture. For us ‘Diversity is the mix. Inclusion is making the mix work’. Therefore, we foster an inclusive environment which allows diversity to flourish. Valuing the diversity of thought and creating an inclusive culture is not only the right thing to do for our people, it’s the smart thing to do for our business.


Ethics & Compliance

At Boehringer Ingelheim, we prioritize the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture, as well as a vital principle in healthcare compliance.



The values and principles that Boehringer Ingelheim has been committed to for over 130 years are firmly embedded in our corporate philosophy. As a family-owned business, we think in generations. Operating sustainably is a major priority. In our desire to serve humanity, we feel responsible for our communities and are respectful of our resources. We work constantly to protect and foster the Environment, Health and Safety (EHS). We envision a healthy planet – by improving human, animal and environmental health.

Safeguarding our planet is at the heart of everything we do. In terms of protecting the environment, our “BE GREEN – Future by Choice” initiative has successfully reduced Boehringer Ingelheim’s energy use, water consumption and CO2 emissions.

We also want our employees to be safe at work – and we are taking concrete steps to ensure that they are: through our “BE SAFE – Zero by Choice” initiative, we have dramatically reduced the amount of accidents per hours worked.


The Making More Health Initiative (MMH)

Making more health” is a long-term initiative with the goal to improve health in communities around the world by identifying and supporting the most promising solutions to challenging health problems. Since 2010, Boehringer Ingelheim and the non-governmental organisation Ashoka are working together in a global partnership. Together with our partner Ashoka we engage actively in single social entrepreneurship projects. Ashoka displays competence in creating change and comes with the network and know-how to identify and to advance social innovators. Boehringer Ingelheim is competent in the healthcare and business sectors. We can provide the social entrepreneurs with a great deal of experience in professional project management. Furthermore, we support the entrepreneurs with our skills, experience, and network. This way of collaboration forms a win-win situation for everyone: For our fellows, for Ashoka and Boehringer Ingelheim.


Access to Healthcare

Boehringer Ingelheim is a global and diverse group of companies and people all driven by the desire to serve mankind by improving human and animal health. We are proud of our long history of philanthropy and social responsibility. Family-owned since our founding in 1885, we feel a special responsibility for our communities and respect for our resources. As we continue to develop breakthrough therapies and healthcare solutions in areas of unmet medical need, access is core to our business and values. We aspire to the sustainable delivery of More Health to humans, animals and communities around the world by building unique initiatives, both commercial and philanthropic, based on partnerships and local empowerment.


Compassionate Use

Boehringer Ingelheim is committed to improving people’s health and quality of life all over the world. Our focus is on developing innovative treatments with potential for break-through developments. A fundamental part of our research and development processes are our clinical trial programs. For patients with serious, life-threatening diseases who are unable to participate in one of our clinical trials, our compassionate use programs may provide access to selected medications before completion of the full regulatory review.


Boehringer Ingelheim International GmbH
Binger Strasse 173  
55216 Ingelheim am Rhein 
Phone +49 – 6132 – 77 0
Fax +49 – 6132 – 72 0


PT. Boehringer Ingelheim Indonesia
Sampoerna Strategic Square, North Tower Lt. 6-7
Jl. Jenderal Sudirman Kav.. 45-46 – Jakarta 12930
Telp: 021 – 5732375
Fax: 021 – 5732383, 5785808

Similar Posts:

Status Perusahaan
Swasta Asing
Rating & Reviews
0 reviews
Contact Form

Sign up for Newsletter

Sign up to get our latest exclusive updates, deals, offers and promotions.